You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AZD1775

Showing 1 - 25 of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer Trial in Tampa, Columbus (Carboplatin, Paclitaxel, AZD1775)

Active, not recruiting
  • Lung Cancer
  • Tampa, Florida
  • +1 more
Feb 2, 2023

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Boston, Houston

Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 12, 2023

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Adavosertib)

Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jun 28, 2022

Uterine Cancer Trial in Boston (AZD1775)

Recruiting
  • Uterine Cancer
  • AZD1775
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 5, 2022

Advanced Solid Tumours Trial in Denver, Sarasota, Nashville (AZD1775, MEDI4736)

Active, not recruiting
  • Advanced Solid Tumours
  • Denver, Colorado
  • +2 more
Aug 18, 2022

Advanced Gastric Adenocarcinoma Trial in Seoul (AZD1775, paclitaxel)

Completed
  • Advanced Gastric Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical center
Jun 13, 2022

Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in United States (Adavosertib)

Suspended
  • Advanced Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Duarte, California
  • +8 more
Mar 15, 2022

Triple-negative Metastatic Breast Cancer Trial in Boston (Cisplatin, AZD1775)

Completed
Has Results
  • Triple-negative Metastatic Breast Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Oct 29, 2021

Solid Tumors Trial run by the NCI (MK-1775 (AZD1775))

Completed
Has Results
  • Solid Tumors
  • MK-1775 (AZD1775)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2021

Pancreatic Cancer Trial (Adavosertib, Gemcitabine)

Withdrawn
  • Pancreatic Cancer
  • (no location specified)
Jun 10, 2022

Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States

Active, not recruiting
  • Ovarian Brenner Tumor
  • +11 more
  • Duarte, California
  • +15 more
Aug 11, 2022

Carcinoma, Squamous Cell of Head and Neck Trial in Chapel Hill (AZD1775, Cisplatin, Intensity Modulated Radiotherapy Treatments)

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • AZD1775
  • +2 more
  • Chapel Hill, North Carolina
    UNC Lineberger Comprehensive Cancer Center
Jun 27, 2021

CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in

Active, not recruiting
Has Results
  • Central Nervous System Embryonal Tumor With Rhabdoid Features
  • +14 more
  • Birmingham, Alabama
  • +23 more
Oct 7, 2022

Cancer Trial in United States (AZD2281, AZD5363, AZD1775)

Active, not recruiting
  • Cancer
  • New Haven, Connecticut
  • +3 more
Sep 14, 2021

Advanced Malignant Solid Tumor Trial in United States (Adavosertib, Carboplatin, Everolimus)

Completed
Has Results
  • Advanced Malignant Solid Neoplasm
  • Aurora, Colorado
  • +7 more
Apr 11, 2022

Small Cell Lung Cancer Trial in Seoul (AZD1775)

Completed
  • Small Cell Lung Cancer
  • AZD1775
  • Seoul, Korea, Republic of
    Samsung Medical Center
Mar 18, 2021

Hypopharynx Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma, Larynx Cancer Trial in United Kingdom (AZD1775,

Completed
  • Hypopharynx Squamous Cell Carcinoma
  • +2 more
  • AZD1775
  • +2 more
  • Birmingham, West Midlands, United Kingdom
  • +5 more
Nov 9, 2022

Metastatic Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v6 and v7, Stage IV Pancreatic Cancer AJCC v6 and v7

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Chicago, Illinois
  • +4 more
Jun 10, 2021

Glioblastoma, GBM Trial in Phoenix (AZD1775)

Completed
  • Glioblastoma
  • GBM
  • AZD1775
  • Phoenix, Arizona
    Barrow Neurological Institute at St. Joseph's Hospital Medical C
Dec 9, 2020

Metastatic Colorectal Cancer Trial in New York (AZD1775, Irinotecan)

Completed
  • Metastatic Colorectal Cancer
  • New York, New York
    Laura and Isaac Perlmutter Cancer Center
Oct 8, 2020

Muscle Invasive Bladder Cancer Trial in Worldwide (AZD4547, MEDI4736, Olaparib)

Active, not recruiting
  • Muscle Invasive Bladder Cancer
  • Los Angeles, California
  • +26 more
Oct 17, 2022

Advanced Solid Tumours Trial in Spain, United Kingdom, United States (Adavosertib)

Active, not recruiting
  • Advanced Solid Tumours
  • Newnan, Georgia
  • +14 more
Mar 15, 2022

Myelofibroses, Acute Myeloid Leukemia, MDS Trial in New York (Combination AZD1775 with AraC, AZD1775 only)

Terminated
Has Results
  • Myelofibroses
  • +2 more
  • Combination AZD1775 with AraC
  • AZD1775 only
  • New York, New York
    NYU Langone Health
May 20, 2020

Uterine Serous Carcinoma Trial in Worldwide (Adavosertib)

Active, not recruiting
  • Uterine Serous Carcinoma
  • Burbank, California
  • +26 more
Jan 10, 2023

Children, Adolescents and Young Adults With Refractory or Recurrent Malignancies Trial in Worldwide (Ribociclib, Topotecan,

Unknown status
  • Children, Adolescents and Young Adults With Refractory or Recurrent Malignancies
  • Copenhagen, Denmark
  • +6 more
Feb 23, 2021